PV pharm branch, vendor, cage 0U9U0

Ended Awarded Last action

Contract number
SPE2D826FAD6A
Awardee
Awarding agency
Obligated
$20,613

Award facts

Contract value 100% obligated
$20,612.76 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $20,612.76 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract vehicle, designated SPE2DX, is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support mechanism. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, fulfills federal medical procurement needs across military and veteran healthcare systems, supplying an extensive portfolio of pharmaceutical products and medical commodities.

Under this delivery order, AmerisourceBergen will provide pharmaceutical products and medical supplies to support Defense Department healthcare requirements. The company's federal contract history demonstrates competitively awarded capabilities across a broad spectrum of therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. Performance will be conducted at the company's corporate office location in Conshohocken, Pennsylvania. This award reflects AmerisourceBergen's established role as a critical vendor within the DLA's Pharmaceutical Prime Vendor Global Program, which strategically awards contracts across multiple regions to ensure comprehensive pharmaceutical support for military healthcare programs worldwide.

Quick answers

Who was awarded contract SPE2D826FAD6A?

SPE2D826FAD6A was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on December 8, 2025.

How much is contract SPE2D826FAD6A worth?

The government has obligated $20,613 on SPE2D826FAD6A.

Is contract SPE2D826FAD6A an order under another contract?

Yes. SPE2D826FAD6A is a delivery order under SPE2DX22D0099, an indefinite delivery contract.

Was contract SPE2D826FAD6A competed?

The extent of competition for SPE2D826FAD6A was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award